• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

L-deprenyl treatment of on-off phenomena in Parkinson's disease.

作者信息

Rinne U K, Siirtola T, Sonninen V

出版信息

J Neural Transm. 1978;43(3-4):253-62. doi: 10.1007/BF01246962.

DOI:10.1007/BF01246962
PMID:745018
Abstract
摘要

相似文献

1
L-deprenyl treatment of on-off phenomena in Parkinson's disease.左旋司来吉兰治疗帕金森病的开关现象
J Neural Transm. 1978;43(3-4):253-62. doi: 10.1007/BF01246962.
2
L-deprenyl in the treatment of Parkinson's disease.左旋司来吉兰治疗帕金森病
J Neural Transm Suppl. 1983;19:283-90.
3
(-)Deprenyl in the treatment of decompensated Parkinson's disease.（-）司来吉兰治疗失代偿期帕金森病
J Neural Transm Suppl. 1986;22:247-52.
4
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease.（-）-司来吉兰可延长帕金森病患者左旋多巴的疗效。
Mod Probl Pharmacopsychiatry. 1983;19:170-6. doi: 10.1159/000407513.
5
Clinical evaluation of deprenyl (selegiline) in the treatment of Parkinson's disease.司来吉兰（丙炔苯丙胺）治疗帕金森病的临床评估。
Acta Neurol Scand Suppl. 1983;95:117-22. doi: 10.1111/j.1600-0404.1983.tb01525.x.
6
Deprenyl (selegiline) in combination treatment of Parkinson's disease.
Acta Neurol Scand Suppl. 1983;95:123-6. doi: 10.1111/j.1600-0404.1983.tb01526.x.
7
Long term treatment with L-deprenyl.用L-司来吉兰进行长期治疗。
J Neural Transm. 1978;43(3-4):239-44. doi: 10.1007/BF01246960.
8
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid.左旋多巴和脱羧酶抑制剂预处理的初发性帕金森病患者中，R-(-)-司来吉兰的疗效与脑脊液中抑郁以及3-甲氧基-4-羟基苯乙二醇（MHPG）、5-羟吲哚乙酸（HIAA）和高香草酸（HVA）水平相关。
Acta Neurol Scand Suppl. 1989;126:153-6. doi: 10.1111/j.1600-0404.1989.tb01795.x.
9
Effect of (-)deprenyl in long-term treatment of Parkinson's disease. A 10-years experience.（-）司来吉兰在帕金森病长期治疗中的作用。十年经验。
J Neural Transm Suppl. 1986;22:219-25.
10
The effect of R-(-)-deprenyl in de novo Parkinson patients on combination therapy with levodopa and decarboxylase inhibitor.R-(-)-司来吉兰对初发帕金森病患者联合左旋多巴和脱羧酶抑制剂治疗的影响。
J Neural Transm Suppl. 1987;25:97-104.

引用本文的文献

1
Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.司来吉兰（丙炔苯丙胺）治疗帕金森病的安全性。
Drug Saf. 1998 Jul;19(1):11-22. doi: 10.2165/00002018-199819010-00002.
2
Mortality associated with selegiline in Parkinson's disease. What do the available data mean?帕金森病中与司来吉兰相关的死亡率。现有数据意味着什么？
Drug Saf. 1997 May;16(5):289-94. doi: 10.2165/00002018-199716050-00001.
3
Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice.儿茶酚-O-甲基转移酶/单胺氧化酶抑制剂与左旋多巴在MPTP处理小鼠中的协同相互作用。

本文引用的文献

1
Determination of 3-methoxy-4-hydroxymandelic acid in urine.尿液中3-甲氧基-4-羟基扁桃酸的测定
Clin Chim Acta. 1962 Mar;7:285-91. doi: 10.1016/0009-8981(62)90022-0.
2
THE DISTRIBUTION OF DOPAMINE AND DOPA IN VARIOUS ANIMALS AND A METHOD FOR THEIR DETERMINATION IN DIVERSE BIOLOGICAL MATERIAL.多巴胺和多巴在各种动物中的分布及其在不同生物材料中的测定方法。
J Pharmacol Exp Ther. 1964 Sep;145:326-36.
3
On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.关于高香草酸在脑和脑脊液中的存在及其荧光法测定
J Neural Transm Gen Sect. 1995;102(1):19-34. doi: 10.1007/BF01276562.
4
Effects of L-deprenyl on human growth hormone secretion.左旋司来吉兰对人生长激素分泌的影响。
J Neural Transm. 1981;51(3-4):223-31. doi: 10.1007/BF01248954.
5
Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa.司来吉兰用于左旋多巴治疗的帕金森病患者反应波动的管理
J Neurol Neurosurg Psychiatry. 1980 Nov;43(11):1016-21. doi: 10.1136/jnnp.43.11.1016.
6
The pharmacology of Parkinson's disease: basic aspects and recent advances.帕金森病的药理学：基础方面与最新进展
Experientia. 1984 Nov 15;40(11):1165-72. doi: 10.1007/BF01946641.
7
Anti-parkinsonian drugs today.当今的抗帕金森病药物。
Drugs. 1984 Sep;28(3):236-62. doi: 10.2165/00003495-198428030-00002.
8
Deprenyl in Parkinson disease: personal experience.司来吉兰治疗帕金森病：个人经验
Ital J Neurol Sci. 1985 Jun;6(2):207-12. doi: 10.1007/BF02229194.
9
Clinical pharmacokinetics of anti-parkinsonian drugs.抗帕金森病药物的临床药代动力学
Clin Pharmacokinet. 1987 Sep;13(3):141-78. doi: 10.2165/00003088-198713030-00002.
10
Parkinson's disease.
CMAJ. 1989 Mar 1;140(5):507-14.
Life Sci (1962). 1963 Jul(7):448-58. doi: 10.1016/0024-3205(63)90132-2.
4
5-Hydroxyindoles in human cerebrospinal fluids.人脑脊液中的5-羟基吲哚
Nature. 1960 Jun 25;186:1050-1. doi: 10.1038/1861050a0.
5
The quantitative determination of 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid) in urine.尿液中3-甲氧基-4-羟基苯乙酸（高香草酸）的定量测定。
J Lab Clin Med. 1965 Sep;66(3):517-25.
6
Treatment of parkinsonism with levodopa.左旋多巴治疗帕金森症。
Arch Neurol. 1969 Oct;21(4):343-54. doi: 10.1001/archneur.1969.00480160015001.
7
[Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)].
Wien Klin Wochenschr. 1969 Sep 26;81(39):677-9.
8
L-Dopa treatment in Parkinson's Disease.帕金森病的左旋多巴治疗。
Eur Neurol. 1970;4(6):348-69. doi: 10.1159/000113990.
9
L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.帕金森病的左旋多巴治疗：对九年经验的批判性综述。
Can Med Assoc J. 1969 Dec 27;101(13):59-68.
10
Modification of Parkinsonism--chronic treatment with L-dopa.帕金森病的改善——左旋多巴的长期治疗
N Engl J Med. 1969 Feb 13;280(7):337-45. doi: 10.1056/NEJM196902132800701.